Evaluation of Circulating YKL-40 Levels in Idiopathic Interstitial Pneumonias

[11] Johansen JS(2008)Immunophenotyping and remodeling process in small airways of idiopathic interstitial pneumonias: functional and prognostic significance Clin Respir J 2 227-238

[12] Vestergaard H(2010)Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD) Respir Med 104 1527-1534

[13] Volck B(2011)‘t Wout E, van Schadewijk A, and Hiemstra P. YKL-40: Novel marker for pro-inflammatory M1 macrophages Eur Respir J 38 3861-660

[14] Price PA(2001)Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters Clin Exp Rheumatol 19 655-2630

[15] Johansen JS(1999)YKL-40 in giant cells and macrophages from patients with giant cell arteritis Arthritis Rheum 42 2624-126

[16] Bigg HF(2002)The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways Biochem J 365 119-5173

[17] Wait R(2008)YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages J Immunol 181 5167-915

[18] Rowan AD(2008)BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience Diagn Cytopathol 36 909-101

[19] Cawston TE(2010)Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction Clin Immunol 137 89-363

[20] Johansen JS(2011)Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Eur Respir J 37 356-174

[11] Johansen JS(2008)Immunophenotyping and remodeling process in small airways of idiopathic interstitial pneumonias: functional and prognostic significance Clin Respir J 2 227-238

[12] Vestergaard H(2010)Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD) Respir Med 104 1527-1534

[13] Volck B(2011)‘t Wout E, van Schadewijk A, and Hiemstra P. YKL-40: Novel marker for pro-inflammatory M1 macrophages Eur Respir J 38 3861-660

[14] Price PA(2001)Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters Clin Exp Rheumatol 19 655-2630

[15] Johansen JS(1999)YKL-40 in giant cells and macrophages from patients with giant cell arteritis Arthritis Rheum 42 2624-126

[16] Bigg HF(2002)The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways Biochem J 365 119-5173

[17] Wait R(2008)YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages J Immunol 181 5167-915

[18] Rowan AD(2008)BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience Diagn Cytopathol 36 909-101

[19] Cawston TE(2010)Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction Clin Immunol 137 89-363

[20] Johansen JS(2011)Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Eur Respir J 37 356-174